239 related articles for article (PubMed ID: 28356060)
21. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
Naga M; Amin M; Algendy D; Elbadry A; Fawzi M; Foda A; Esmat S; Sabry D; Rashed L; Gabal S; Kamal M
World J Gastroenterol; 2015 Oct; 21(39):11141-51. PubMed ID: 26494968
[TBL] [Abstract][Full Text] [Related]
22. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
23. The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients.
Bader El Din NG; Farouk S; El-Shenawy R; Elhady MM; Ibrahim MK; Dawood RM; Salem AM; El Awady MK
Viral Immunol; 2017 Mar; 30(2):127-135. PubMed ID: 28151059
[TBL] [Abstract][Full Text] [Related]
24. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
[TBL] [Abstract][Full Text] [Related]
25. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ
Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885
[TBL] [Abstract][Full Text] [Related]
26. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
27. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
Sharma P; Balan V; Hernandez J; Rosati M; Williams J; Rodriguez-Luna H; Schwartz J; Harrison E; Anderson M; Byrne T; Vargas HE; Douglas DD; Rakela J
Dig Dis Sci; 2004 Jan; 49(1):25-9. PubMed ID: 14992430
[TBL] [Abstract][Full Text] [Related]
28. Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.
Newberry EP; Xie Y; Kennedy SM; Graham MJ; Crooke RM; Jiang H; Chen A; Ory DS; Davidson NO
Hepatology; 2017 Mar; 65(3):836-852. PubMed ID: 27862118
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis.
Verdi H; Koytak ES; Onder O; Ergül AA; Cinar K; Idilman R; Erden E; Bozdayi AM; Yurdaydin C; Uzunalimoglu O; Bozkaya H
J Investig Med; 2005 Nov; 53(7):353-9. PubMed ID: 16297361
[TBL] [Abstract][Full Text] [Related]
30. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with steatosis in liver biopsies of individuals with chronic hepatitis C infection in southern Brazil.
Giustina RD; Marconcini ML; Bansho ET; Tonon D; Pasinato AP; Dantas-Corrêa EB; Schiavon LL; Narciso-Schiavon JL
Arab J Gastroenterol; 2015 Jun; 16(2):59-62. PubMed ID: 26169501
[TBL] [Abstract][Full Text] [Related]
32. Hepatic steatosis in Iranian patients with chronic hepatitis C.
Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
[TBL] [Abstract][Full Text] [Related]
33. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus diversity and hepatic steatosis.
Roingeard P
J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
[TBL] [Abstract][Full Text] [Related]
35. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation.
Hwang SJ; Luo JC; Chu CW; Lai CR; Lu CL; Tsay SH; Wu JC; Chang FY; Lee SD
J Gastroenterol Hepatol; 2001 Feb; 16(2):190-5. PubMed ID: 11207900
[TBL] [Abstract][Full Text] [Related]
36. A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipids.
Schneider CV; Hehl L; Creasy KT; Vitali C; Vell MS; Vujkovic M; Park J; Scorletti E; Seeling KS; Rendel MD; Conlon DM; Huang H; Zandvakili I; Valmiki S; ; Schneider KM; Hussain MM; Rader DJ
Aliment Pharmacol Ther; 2023 Jul; 58(2):238-249. PubMed ID: 37248657
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.
Wójcik K; Jabłonowska E; Omulecka A; Piekarska A
World J Gastroenterol; 2014 Aug; 20(30):10449-56. PubMed ID: 25132761
[TBL] [Abstract][Full Text] [Related]
38. Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes.
Sumida Y; Kanemasa K; Hara T; Inada Y; Sakai K; Imai S; Yoshida N; Yasui K; Itoh Y; Okanoue T; Yoshikawa T
J Gastroenterol Hepatol; 2011 May; 26(5):836-42. PubMed ID: 21054524
[TBL] [Abstract][Full Text] [Related]
39. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men.
St-Pierre J; Lemieux I; Miller-Felix I; Prud'homme D; Bergeron J; Gaudet D; Nadeau A; Despres JP; Vohl MC
Atherosclerosis; 2002 Feb; 160(2):317-24. PubMed ID: 11849654
[TBL] [Abstract][Full Text] [Related]
40. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease.
Iwata R; Baur K; Stieger B; Mertens JC; Daly AK; Frei P; Braun J; Vergopoulos A; Stickel F; Sabrane K; Martin IV; Schmitt J; Goetze O; Day CP; Müllhaupt B; Geier A;
Clin Sci (Lond); 2011 Apr; 120(7):287-96. PubMed ID: 20883210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
